Precipio Reschedules Q2-2021 Shareholder Update Call
August 20, 2021 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be rescheduling its Q2-2021 update call from Monday August 23rd to...
Precipio Corrects Announcement of Q2-2021 Shareholder Update Call
August 13, 2021 10:48 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET....
Precipio Announces Q2-2021 and year-end Shareholder Update Call
August 12, 2021 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET....
Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M
July 28, 2021 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., July 28, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO), announces preliminary unaudited revenues for Q2-2021 demonstrating continued...
Precipio Terminates its Equity Line
June 15, 2021 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 15, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO), announces that as part of management’s review of its current financing arrangements,...
Precipio Launches HemeScreen® Anemia Panel, a One-of-its-Kind Testing Tool
June 08, 2021 10:30 ET
|
Precipio, Inc.
Laboratories can use this rapid, cost effective test to distinguish malignancy-driven anemia from other causes NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
Precipio Announces Q1-2021 and year-end Shareholder Update Call
May 14, 2021 16:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 14, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2021 corporate update call on Thursday, May 20th at 5:00...
Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time
May 10, 2021 10:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 10, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched a new, four-hour Acute Myeloid Leukemia (AML)...
Precipio Launches its Rapid COVID-19 Antibody test on Amazon Platform
May 03, 2021 09:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 03, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has successfully launched its COVID-19 rapid antibody test (20...
Current Signed Customers Expected to Generate $1M Annualized Reported Revenues from Precipio’s HemeScreen POL Offering by Q4-2021
April 26, 2021 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 26, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that currently, the contracted annualized revenues from signed customers...